Flu Vaccine - Institute for Respiratory Health

Flu Vaccine

Study Outline

The study aims to evaluate an investigational vaccine against diseases caused by respiratory syncytial virus (RSV) when given at the same time as the approved annual influenza vaccine.
To find out if this trial is suitable for you please register below or contact our Clinical Trials Team at admin@resphealth.uwa.edu.au or phone 6151 0888.

Eligibility & Requirements

  • Healthy adults aged 65 to 85 years
  • Willing and able to follow a study treatment plan of scheduled study visits, lab tests and other study
  • Procedures for the duration of the study, approximately 12 months


What's Involved

  • You will be required to attend one longer visit to Sir Charles Gairdner Hospital to receive the investigational vaccine or placebo and also the annual approved influenza vaccine. You will then need to attend four more short visits over the next 12 months.
This Clinical Trial is currently Closed

Please register your interest for future clinical trials and we will contact you when a suitable trial becomes available.

Current Clinical Trials